362606-18-6

Basic information

• Product Name: (1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine
• Synonyms: (1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine
• CAS NO: 362606-18-6
• Molecular Formula: C9H13 N3
• Molecular Weight: 0
• Mol File: 362606-18-6.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: (1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine(362606-18-6)
• EPA Substance Registry System: (1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine(362606-18-6)

Safety Data

• Hazardous Substances Data: 362606-18-6(Hazardous Substances Data)

Usage

Description

(1,2,3,4-Tetrahydro-[1,6]naphthyridin-8-yl)-methylamine, also known as THNMA, is a chemical compound belonging to the naphthyridine family with the molecular formula C11H15N3. It is recognized for its diverse biological activities, such as antimicrobial, antiprotozoal, and anticancer properties, which make it a valuable candidate for pharmaceutical research and development.

Uses

Used in Pharmaceutical Industry:
THNMA is utilized as a lead compound for the development of new drugs due to its antimicrobial, antiprotozoal, and anticancer properties. Its versatile nature allows it to be a potential therapeutic agent for various diseases and conditions.
Used in Antimicrobial Applications:
THNMA serves as an antimicrobial agent, targeting a range of bacteria and helping to combat infections. Its ability to inhibit bacterial growth makes it a useful component in the development of antibiotics and antimicrobial treatments.
Used in Antiprotozoal Applications:
As an antiprotozoal agent, THNMA is employed to treat infections caused by protozoan parasites. This application is particularly relevant for diseases like malaria, where new treatments are constantly being sought to combat drug-resistant strains.
Used in Anticancer Applications:
THNMA is used as an anticancer agent, exhibiting potential in targeting and inhibiting the growth of cancer cells. Its incorporation into oncology research and drug development could lead to the creation of novel cancer therapies.
Used in Drug Development Research:
THNMA is utilized in drug development research as a compound with potential for modification and optimization. Its structure and properties make it a suitable candidate for further investigation and development into more effective and targeted therapeutic agents.